tiprankstipranks
Trending News
More News >
Health and Plant Protein Group Limited (AU:HPP)
:HPP

Health and Plant Protein Group Limited (HPP) AI Stock Analysis

Compare
0 Followers

Top Page

AU

Health and Plant Protein Group Limited

(Frankfurt:HPP)

Rating:43Neutral
Price Target:
Health and Plant Protein Group Limited faces substantial financial and operational challenges. The absence of revenue, continued net losses, and negative cash flows are critical concerns. Although the company has no debt, declining assets and cash reserves pose risks to sustainability. The lack of market momentum or positive valuation factors further diminishes the stock's attractiveness.

Health and Plant Protein Group Limited (HPP) vs. iShares MSCI Australia ETF (EWA)

Health and Plant Protein Group Limited Business Overview & Revenue Model

Company DescriptionHealth and Plant Protein Group Limited (HPP) is a company engaged in the production and distribution of plant-based nutrition products. It operates within the health and wellness sector, focusing on providing high-quality plant protein and related products to meet the growing consumer demand for sustainable and healthy dietary options. HPP's core products include a range of plant-based protein ingredients and consumer-ready products designed to cater to health-conscious individuals and businesses seeking alternative protein sources.
How the Company Makes MoneyHPP makes money primarily through the sale of its plant-based protein products. The company generates revenue by supplying plant protein ingredients to food manufacturers and retailers who incorporate these ingredients into their own products. Additionally, HPP develops and sells its own branded consumer products, which are distributed through various retail and online channels. Key revenue streams include bulk ingredient sales to other businesses and direct-to-consumer product sales. Strategic partnerships with food companies, retailers, and distributors enhance its market reach and contribute significantly to its earnings by expanding the availability and visibility of HPP's products in different regions.

Health and Plant Protein Group Limited Financial Statement Overview

Summary
Health and Plant Protein Group Limited is facing severe financial challenges, with zero revenue and ongoing net losses. Despite a debt-free balance sheet, the company's eroding asset base and negative cash flow signal significant financial instability.
Income Statement
35
Negative
Health and Plant Protein Group Limited has faced significant challenges in revenue generation, with total revenue dropping to zero in the latest fiscal year. The company has been experiencing negative net income consistently over recent years, reflecting ongoing profitability issues. The gross profit margin is non-existent due to the absence of revenue, and both EBIT and EBITDA margins are negative, indicating operational inefficiencies. The revenue growth trajectory has been negative, with a complete collapse from prior years' levels, which is a major concern for future prospects.
Balance Sheet
50
Neutral
The balance sheet of the company shows a strong equity position with a positive stockholder's equity and no debt, which reflects financial stability. The equity ratio is relatively high, suggesting that the company is not reliant on debt financing. However, declining total assets and a significant reduction in cash reserves are potential red flags for long-term sustainability. The company's ability to leverage its assets effectively is questionable, and the trend of diminishing equity suggests potential future liquidity issues.
Cash Flow
40
Negative
The cash flow analysis reveals significant negative operating cash flow, indicating challenges in generating cash from core operations. There is no free cash flow growth, with consistently negative free cash flow, reflecting the company's inability to generate cash after capital expenditures. The operating cash flow to net income ratio is unfavorable, suggesting that the company's net income does not translate effectively into cash flow. The financial health is further strained by negative financing cash flow, which may limit future growth opportunities.
BreakdownTTMJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income Statement
Total Revenue-25.00K0.000.0042.25M36.23M42.12M
Gross Profit-25.00K0.00-131.00K11.79M1.39M9.88M
EBITDA323.00K226.00K-2.79M-1.15M-9.76M1.35M
Net Income-96.00K-801.00K-16.83M665.00K-10.11M-7.57M
Balance Sheet
Total Assets6.23M6.26M8.56M56.14M49.95M73.60M
Cash, Cash Equivalents and Short-Term Investments904.00K1.29M3.75M3.47M2.73M2.67M
Total Debt0.000.000.0021.18M20.22M27.79M
Total Liabilities125.00K112.00K1.27M31.09M29.02M47.21M
Stockholders Equity6.11M6.15M7.29M25.04M20.93M26.39M
Cash Flow
Free Cash Flow-845.00K-1.34M-7.34M576.00K-3.54M-292.00K
Operating Cash Flow-845.00K-1.34M-7.34M1.40M-2.62M860.00K
Investing Cash Flow66.00K-592.00K16.71M-948.00K5.94M-1.39M
Financing Cash Flow-513.00K-513.00K-8.84M297.00K-3.16M1.74M

Health and Plant Protein Group Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (49)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
AUBGA
59
Neutral
€1.67B48.843.35%2.19%4.28%
AUSHV
51
Neutral
$578.38M17.547.05%75.76%
49
Neutral
AU$2.50B4.42-64.25%2.77%36.51%13.14%
AUAHF
46
Neutral
€31.59M-23.00%-2.14%11.40%
AUHPP
43
Neutral
AU$5.16M
98.35%
AUEAT
32
Underperform
AU$5.13M
7.02%-44.64%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:HPP
Health and Plant Protein Group Limited
0.04
0.00
0.00%
AU:BGA
Bega Cheese Limited
5.48
1.30
31.10%
AU:AHF
Australian Dairy Nutritionals Group
0.04
0.02
90.91%
AU:SHV
Select Harvests
4.07
0.51
14.20%
AU:EAT
IncentiaPay Ltd.

Health and Plant Protein Group Limited Corporate Events

Health and Plant Protein Group Limited Reports Reduced Losses Following Divestiture
Feb 17, 2025

Health and Plant Protein Group Limited reported a net loss after tax of $43,000 for the half-year ending 31 December 2024, a significant improvement from the $748,000 loss in the previous year. This improvement is largely due to the divestiture of its macadamia division, which halted business operations and led to the suspension of trading in HPP shares. The company is awaiting clearance of US$3.9 million from the IRS, with uncertainty over timing and amount due to processing delays. The half-year also saw a decrease in corporate overheads and an unrealized foreign exchange gain.

Health and Plant Protein Group Limited Releases Half-Year Report
Feb 17, 2025

Health and Plant Protein Group Limited has released its half-year report for the period ending December 31, 2024. The report highlights the company’s financial performance and operational updates, providing insights into its current state and strategic direction. While specific financial figures are not detailed, the report serves as a significant update for stakeholders regarding the company’s progress and market positioning.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 08, 2025